Abstract
Background: Human Immunodeficiency Virus (HIV) is the causative agent of Acquired Immunodeficiency Syndrome (AIDS) that imposes a global health burden. Therefore, HIV therapeutic agents have been discovery and development.
Objective: To construct Quantitative-structure Activity Relationship (QSAR) models of betulinic acid derivatives with anti-HIV activity using Simplified Molecular-Input Line-Entry System (SMILES)- based descriptors.
Methods: A data set of 107 betulinic acid derivatives and their anti-HIV activity was used to develop QSAR models. The SMILES format of the compounds was employed as descriptors for model construction using the CORAL software by means of the Monte Carlo method.
Results: Constructed QSAR models provided good correlation coefficients (R2) and root mean square error (RMSE) with values in the range of 0.5660-0.5890 and 0.963-1.020, respectively, for the training set, R2 value of 0.7206-0.7837 and RMSE as 0.609-1.250, respectively, for the calibration set, and R2 value of 0.6257-0.7748 and RMSE as 0.837-0.995, respectively, for the validation set. The best QSAR model displayed statistical parameters for training set: R2 = 0.5660 and RMSE = 0.963; calibration set: R2 = 0.7273 and RMSE = 0.609, and validation set: R2 = 0.7748 and RMSE = 0.972. In addition, features of the molecular structure that are promoters of the endpoint increase and decrease were defined and discussed. These are the basis for the mechanistic interpretation of the suggested models.
Conclusion: These findings provide useful knowledge for guiding the design of novel compounds with promising anti-HIV activity.
Keywords: Betulinic acid, AIDS, Anti-HIV agent, SMILES, QSAR, betulinic acid.
Current Computer-Aided Drug Design
Title:Quantitative Structure-activity Relationship Study of Betulinic Acid Derivatives Against HIV using SMILES-based Descriptors
Volume: 14 Issue: 2
Author(s): Apilak Worachartcheewan*, Alla P. Toropova, Andrey A. Toropov, Suphakit Siriwong, Jatupat Prapojanasomboon, Virapong Prachayasittikul and Chanin Nantasenamat
Affiliation:
- Department of Community Medical Technology, Faculty of Medical Technology, Mahidol University, Bangkok 10700,Thailand
Keywords: Betulinic acid, AIDS, Anti-HIV agent, SMILES, QSAR, betulinic acid.
Abstract: Background: Human Immunodeficiency Virus (HIV) is the causative agent of Acquired Immunodeficiency Syndrome (AIDS) that imposes a global health burden. Therefore, HIV therapeutic agents have been discovery and development.
Objective: To construct Quantitative-structure Activity Relationship (QSAR) models of betulinic acid derivatives with anti-HIV activity using Simplified Molecular-Input Line-Entry System (SMILES)- based descriptors.
Methods: A data set of 107 betulinic acid derivatives and their anti-HIV activity was used to develop QSAR models. The SMILES format of the compounds was employed as descriptors for model construction using the CORAL software by means of the Monte Carlo method.
Results: Constructed QSAR models provided good correlation coefficients (R2) and root mean square error (RMSE) with values in the range of 0.5660-0.5890 and 0.963-1.020, respectively, for the training set, R2 value of 0.7206-0.7837 and RMSE as 0.609-1.250, respectively, for the calibration set, and R2 value of 0.6257-0.7748 and RMSE as 0.837-0.995, respectively, for the validation set. The best QSAR model displayed statistical parameters for training set: R2 = 0.5660 and RMSE = 0.963; calibration set: R2 = 0.7273 and RMSE = 0.609, and validation set: R2 = 0.7748 and RMSE = 0.972. In addition, features of the molecular structure that are promoters of the endpoint increase and decrease were defined and discussed. These are the basis for the mechanistic interpretation of the suggested models.
Conclusion: These findings provide useful knowledge for guiding the design of novel compounds with promising anti-HIV activity.
Export Options
About this article
Cite this article as:
Worachartcheewan Apilak *, Toropova P. Alla , Toropov A. Andrey, Siriwong Suphakit , Prapojanasomboon Jatupat , Prachayasittikul Virapong and Nantasenamat Chanin , Quantitative Structure-activity Relationship Study of Betulinic Acid Derivatives Against HIV using SMILES-based Descriptors, Current Computer-Aided Drug Design 2018; 14 (2) . https://dx.doi.org/10.2174/1573409914666180112094156
DOI https://dx.doi.org/10.2174/1573409914666180112094156 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
Call for Papers in Thematic Issues
Artificial Intelligence in Biomedical Research: Enhancing Data Analysis for Drug Discovery and Development
This thematic issue highlights the transformative impact of Artificial Intelligence (AI), with a particular focus on Machine Learning (ML) and Deep Learning (DL) techniques, in advancing biomedical research. As a result of these cutting-edge AI methodologies, drug discovery and development are revolutionizing data analysis. Rapid advances in artificial intelligence technologies ...read more
Computer-Aided Drug Discoveries for Emerging Diseases
Computer-aided drug design is a rapidly growing research field that continues to gain momentum, attracting increasing interest from the scientific community. This trend is largely driven by the growing utilization of machine learning and artificial intelligence in drug design and discovery. Artificial Intelligence has proven efficacy across various applications, including ...read more
Deep Learning Approaches in Bioinformatics for Computer-Aided Drug Development Targeting Brain Tumors
The integration of deep learning and bioinformatics is revolutionizing the field of computer-aided drug development, particularly in the fight against brain tumors one of the most aggressive and lethal types of cancer. Brain tumors present significant challenges due to their heterogeneity and complexity, which require novel approaches for early diagnosis ...read more
Emerging Trends in Computer-Aided Drug and Healthcare Solutions
This special issue aims to further the advancement of knowledge in drug design, healthcare innovations, and medical solutions by leveraging modern computational techniques. In recent years, computer-aided drug design has transformed the approach to medicinal chemistry, accelerating the drug discovery process and fostering innovation. The goal of this issue is ...read more

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Spectrum of Airway Disease Associated with Rheumatoid Arthritis
Current Respiratory Medicine Reviews Medicinal and Therapeutic Potential of Herbs and Plant Metabolites / Extracts Countering Viral Pathogens - Current Knowledge and Future Prospects
Current Drug Metabolism Advanced In Silico Approaches for Drug Discovery: Mining Information from Multiple Biological and Chemical Data Through mtk- QSBER and pt-QSPR Strategies
Current Medicinal Chemistry A Review on PCR and POC-PCR - A Boon in the Diagnosis of COVID-19
Current Pharmaceutical Analysis Multiscale Modelling of Relationships between Protein Classes and Drug Behavior Across all Diseases Using the CANDO Platform
Mini-Reviews in Medicinal Chemistry Chitosan Oligomer and Zinc Oxide Nanoparticles for Treating Wastewaters: US20190134086 Patent Evaluation
Recent Patents on Biotechnology Synthesis and Biological Properties of Dihydro-Oxadiazine-Based Heterocyclic Derivatives
Mini-Reviews in Medicinal Chemistry Is It Possible to Control the Outbreak of COVID-19 in Dharavi, Asia’s Largest Slum Situated in Mumbai?
Anti-Infective Agents Second-Generation Antipsychotic Agents: A Review of Safety Profiles
Current Psychiatry Reviews CRF Receptor Antagonists: Utility in Research and Clinical Practice
Current Medicinal Chemistry The Influence of DMPK as an Integrated Partner in Modern Drug Discovery
Current Drug Metabolism Computational Insights for the Discovery of Non-ATP Competitive Inhibitors of MAP Kinases
Current Pharmaceutical Design Emerging β-Amyloid Therapies for the Treatment of Alzheimers Disease
Current Pharmaceutical Design Structural and Electronic Factors Influencing the Selective Inhibition of COX-2
Mini-Reviews in Medicinal Chemistry Amyloid-β Aggregation Inhibitory and Neuroprotective Effects of Xanthohumol and its Derivatives for Alzheimer’s Diseases
Current Alzheimer Research Binding Modes and Pharmacophore Modelling of Thermolysin Inhibitors
Mini-Reviews in Medicinal Chemistry Antiviral Effects and Mechanisms of Green Tea Catechins on Influenza: A Perception on Combating Symptoms from COVID-19
Current Topics in Medicinal Chemistry Pharmacotherapy in Neonatal and Pediatric Extracorporeal Membrane Oxygenation (ECMO)
Current Drug Metabolism Piperine and Derivatives: Trends in Structure-Activity Relationships
Current Topics in Medicinal Chemistry On the Structural Basis of the Hypertensive Properties of Angiotensin II: A Solved Mystery or a Controversial Issue?
Current Topics in Medicinal Chemistry